Description:

Ascon‑F Inhaler is a fixed‑dose combination of an inhaled corticosteroid (Beclometasone Dipropionate) and a long‑acting beta‑2 agonist (Formoterol Fumarate). It is indicated for the long‑term management of asthma and chronic obstructive pulmonary disease (COPD). The inhaler provides both anti‑inflammatory and bronchodilator effects, helping patients achieve better symptom control and improved lung function.

Key Features:

Effective in bronchial asthma requiring maintenance therapy
Controls COPD symptoms such as wheezing, shortness of breath, and chest tightness
Provides rapid bronchodilation (Formoterol acts within minutes) and sustained relief up to 12 hours
Reduces airway inflammation, edema, and mucus production
Convenient metered‑dose inhaler form with 200 puffs

Dosage & Administration:

Adults: 1–2 puffs twice daily (as prescribed by physician)
Not recommended for children under 18 years
Rinse mouth with water after use to reduce risk of oral thrush
Not intended for acute asthma attacks; use a rescue inhaler if needed

Possible Side Effects:

Hoarseness or throat irritation
Oral thrush (fungal infection)
Headache, tremor, or palpitations
Mild cough after inhalation (Most side effects are mild and can be minimized with proper inhaler technique)